A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Health care has had to adapt rapidly to COVID-19, and this in turn has highlighted a pressing need for tools to facilitate remote visits and monitoring. Digital health technology, including body-worn devices, offers a solution using digital outcomes to measure and monitor disease status and provide outcomes meaningful to both patients and health care professionals. Remote monitoring of physical mobility is a prime example, because mobility is among the most advanced modalities that can be assessed digitally and remotely. Loss of mobility is also an important feature of many health conditions, providing a read-out of health as well as a target for intervention. Real-world, continuous digital measures of mobility (digital mobility outcomes or DMOs) provide an opportunity for novel insights into health care conditions complementing existing mobility measures. Accepted and approved DMOs are not yet widely available. The need for large collaborative efforts to tackle the critical steps to adoption is widely recognised. Mobilise-D is an example. It is a multidisciplinary consortium of 34 institutions from academia and industry funded through the European Innovative Medicines Initiative 2 Joint Undertaking. Members of Mobilise-D are collaborating to address the critical steps for DMOs to be adopted in clinical trials and ultimately health care. To achieve this, the consortium has developed a roadmap to inform the development, validation and approval of DMOs in Parkinson’s disease, multiple sclerosis, chronic obstructive pulmonary disease and recovery from proximal femoral fracture. Here we aim to describe the proposed approach and provide a high-level view of the ongoing and planned work of the Mobilise-D consortium. Ultimately, Mobilise-D aims to stimulate widespread adoption of DMOs through the provision of device agnostic software, standards and robust validation in order to bring digital outcomes from concept to use in clinical trials and health care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Ekelund, U., Tarp, J., Steene-Johannessen, J., Hansen, B. H., Jefferis, B., Fagerland, M. W., Whincup, P., Diaz, K. M., Hooker, S. P., Chernofsky, A., et al. (2019) · BMJ · doi:10.1136/bmj.l4570 · Cited by 1,769
Two-, six-, and 12-minute walking tests in respiratory disease.
Butland, R. J., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982) · BMJ · doi:10.1136/bmj.284.6329.1607 · Cited by 1,668
White Paper: “Walking Speed: the Sixth Vital Sign”
Fritz, S., & Lusardi, M. (2009) · Journal of Geriatric Physical Therapy · doi:10.1519/00139143-200932020-00002 · Cited by 1,390
Continuous Monitoring of Turning in Patients with Movement Disability
El-Gohary, M., Pearson, S., McNames, J., Mancini, M., Horak, F., Mellone, S., & Chiari, L. (2013) · Sensors · doi:10.3390/s140100356 · Cited by 258
Traditional and Digital Biomarkers: Two Worlds Apart?
Babrak, L. M., Menetski, J., Rebhan, M., Nisato, G., Zinggeler, M., Brasier, N., Baerenfaller, K., Brenzikofer, T., Baltzer, L., Vogler, C., et al. (2019) · Digital Biomarkers · doi:10.1159/000502000 · Cited by 181
Cited by
Palmerini, L., Reggi, L., Bonci, T., Del Din, S., Micó-Amigo, M. E., Salis, F., Bertuletti, S., Caruso, M., Cereatti, A., Gazit, E., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-01930-9 · Cited by 52
Self-citationThe value of walking: A systematic review on mobility and healthcare costs
Wohlrab, M., Klenk, J., Delgado-Ortiz, L., Chambers, M., Rochester, L., Zuchowski, M., Schwab, M., Becker, C., & Jaeger, S. U. (2022) · European Review of Aging and Physical Activity · doi:10.1186/s11556-022-00310-3 · Cited by 26
Self-citationKeogh, A., Argent, R., Doherty, C., Duignan, C., Fennelly, O., Purcell, C., Johnston, W., & Caulfield, B. (2024) · Sensors · doi:10.3390/s24123780 · Cited by 14
Self-citation
Metadata
- Authors
- Rochester, L., Mazzà, C., Mueller, A., Caulfield, B., McCarthy, M., Becker, C., Miller, R., Piraino, P., Viceconti, M., Dartee, W. P., Garcia-Aymerich, J., Aydemir, A. A., Vereijken, B., Arnera, V., Ammour, N., Jackson, M., Hache, T., Roubenoff, R., & on behalf of the Mobilise-D Consortium
- Venue
- Digital Biomarkers
- Publisher
- S. Karger AG
- Published
- 2020-11-26
- Volume
- 4
- Issue
- Suppl. 1
- Pages
- 13-27
- ISSN
- 2504-110X (ISSN-L)
- OpenAlex
- W3107368598
- Cited by
- 140
- References
- 12
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. https://app.cochat.ai/papers/10.1159/000512513
- The paper
- Rochester, L., Mazzà, C., Mueller, A., Caulfield, B., McCarthy, M., Becker, C., Miller, R., Piraino, P., Viceconti, M., Dartee, W. P., Garcia-Aymerich, J., Aydemir, A. A., Vereijken, B., Arnera, V., Ammour, N., Jackson, M., Hache, T., Roubenoff, R., & on behalf of the Mobilise-D Consortium. (2020). A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. Digital Biomarkers. https://doi.org/10.1159/000512513
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.